DGAT1 and obesity due to melanocortin 4 receptor deficiency: DGAT1 plays a role in VLDL synthesis; increased plasma VLDL concentrations may promote obesity and thus DGAT1 is considered a potential therapeutic target of obesity and associated complications [54].